435 Results
Document
Dec 2023
Document
Dec 2023
Drug
Mar 2024
Guidelines and Advice
Status: Current
ID: GL 19-7
ID: GL 19-7
Mar 2024
This is FR page
Symptom Management
Regimen
Document
Document
Document
Sep 2024
Document
Sep 2024
Document
Oct 2024